Dr. Reddy’s Laboratories informs about press release

29 Jul 2024 Evaluate

Dr. Reddy’s Laboratories has informed that it enclosed a Press Release on ‘Dr. Reddy’s receives positive CHMP opinion from European Medicines Agency for its proposed Rituximab biosimilar’.

The above information is a part of company’s filings submitted to BSE.



Dr. Reddys Lab Share Price

1194.55 -19.40 (-1.60%)
21-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.65
Dr. Reddys Lab 1194.55
Cipla 1465.65
Lupin 2043.30
Zydus Lifesciences 944.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.